Page last updated: 2024-08-24

fluorodeoxyglucose f18 and 2,4-thiazolidinedione

fluorodeoxyglucose f18 has been researched along with 2,4-thiazolidinedione in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cendes, F; Cintra, RM; de-Lima-JĂșnior, JC; Folli, F; Monfort-Pires, M; Rachid, B; Ramos, CD; Rodovalho, S; Van de Sande-Lee, S; Velloso, LA1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and 2,4-thiazolidinedione

ArticleYear
Effect of pioglitazone treatment on brown adipose tissue volume and activity and hypothalamic gliosis in patients with type 2 diabetes mellitus: a proof-of-concept study.
    Acta diabetologica, 2019, Volume: 56, Issue:12

    Topics: Adipose Tissue, Brown; Adult; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Hypothalamus; Male; Middle Aged; Obesity; Organ Size; Overweight; Pioglitazone; Positron Emission Tomography Computed Tomography; Proof of Concept Study; Thiazolidinediones

2019